Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis

Yun-Kai Dai; Zhi-Min Zhao; Chenghai Liu

doi:10.3389/fphar.2022.942841

Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis

Front Pharmacol. 2022 Jul 12:13:942841. doi: 10.3389/fphar.2022.942841. eCollection 2022.

Authors

Yun-Kai Dai¹, Zhi-Min Zhao^{1

2}, Chenghai Liu^{1

2

3}

Affiliations

¹ Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
² Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai, China.
³ Key Laboratory of Liver and Kidney Diseases, Ministry of Education, Shanghai, China.

Abstract

Objectives: To analyze the research hotspots, evolution, and trends of the treatment of liver fibrosis in the recent 20 years, bibliometric and knowledge-map analysis were used. Methods: Publications associated with the treatment of liver fibrosis were retrieved from the Web of Science Core Collection on 16 April 2022. CiteSpace 5.8.R3 and VOSviewer 1.6.18 were calculated to perform bibliometric and knowledge-map analysis. Results: A total of 72,686 authors from 200 institutions in 134 countries/regions published 15,237 studies in different academic journals. United States was the most productive country, and Shanghai Jiao Tong University was the most published institution. Trauner Michael had the most published articles, whereas Scott L. Friedman was the most frequently co-cited author. Moreover, there was frequent inter-institution cooperation between countries in the years 2015 and after, but the before years showed rare inter-institution cooperation. The journal HEPATOLOGY was both the most published publication and the most frequently co-cited one in this field. Screened keywords, such as virus infection, inflammation, oxidative stress, activation of hepatic stellate cell (HSC), and hepatocellular apoptosis, could be both therapeutic targets and pathological mechanisms in terms of liver fibrosis. Furthermore, long-term suppression of hepatitis B virus replication and the activation of HSC were the latest hotspots and topics related to the treatment of liver fibrosis. Besides, the treatments of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis were also involved in the treatment of liver fibrosis, which were both emerging topics and rapidly developing hot fields. Conclusion: This bibliometric analysis conducted a full overview of the treatment of liver fibrosis, which provided important clues and ideas for scholars focusing on this field. Not only that, the field is still in a stage of rapid development and will continue to be a research hotspot in the future.

Keywords: Citespace; VOSviewer; bibliometric; knowledge-map; treatment of liver fibrosis.